BACKGROUND The purpose of this study was to evaluate diabetes control, as measured by hemoglobin A1c (HbA1c) improvements among African American and Hispanic patients receiving conventional clinical treatment combined with a bilingual diabetes educator using culturally and linguistically appropriate educational materials. This study also sought to estimate the healthcare cost savings resulting ...

background: diabetes is a well-known risk factor for acute ischemic stroke (ais). some recent studies point to hemoglobin a1c (hba1c) may have prognostic value in nondiabetic and diabetic patients with ischemic stroke (is). the aim of this study was to evaluate the prognostic value of hba1c on mortality and morbidity in ais patients with and without diabetic. methods: in this prospective observ...

Bottom line Compared with placebo, semaglutide and liraglutide, but not lixisenatide, reduce cardiovascular disease (CVD) for about 1 in 50 patients with diabetes with existing CVD over 2 to 4 years, irrespective of specific hemoglobin A1c (HbA1c) targets. They reduce weight, but about 1 in 25 more patients than in the placebo group stopped treatment owing to gastrointestinal effects. Some unce...

RESEARCH DESIGN AND METHODS—The follow-up included subjects who participated in the early intervention of oral insulin (1994–2003) to prevent or delay type 1 diabetes. A telephone survey was conducted in 2009 to determine whether diabetes had been diagnosed and, if not, an oral glucose tolerance test (OGTT), hemoglobin A1c (HbA1c), and autoantibody levels were obtained in all subjects who agree...

Abstract Background Glucose monitoring is vital for glycemic control in patients with diabetes mellitus (DM). Continuous glucose (CGM) measures whole-day levels. Hemoglobin A1c (HbA1c) a outcome predictor DM. Methods This study investigated the relationship between HbA1c and CGM, which remained unclear hitherto. Data of DM (n = 91) who received CGM testing (1–3 months before after CGM) were ret...

Objectives: Due to the important influence of glycemic control on oral health, this study aimed compare gingival index and decayed, missing, filled teeth (DMFT) in participants with type 2 diabetes mellitus receiving insulin metformin. Materials Methods: In cross-sectional study, 130 treated metformin were studied two groups based treatment. The information for DMFT indices obtained using exami...

This was a 24-week randomized, double-blind, placeboand active-controlled study of 0.5–3.0 mg INT131 versus 45 mg pioglitazone or placebo daily in 367 subjects with T2D on sulfonylurea or sulfonylurea plus metformin. The primary efficacy analysis was the comparison of change from baseline to week 24 in hemoglobin A1c (HbA1c) across treatment groups. Fluid status was assessed with a prospective ...

The prevalence of diabetes is higher amongst individuals infected with HIV. The major contributor to hyperglycaemia is thought to be iatrogenic, with protease inhibitors being most commonly associated to insulin resistance. This article is to update general practitioners on the diagnosis and management of diabetes in HIV-infected patients. Specific considerations are highlighted including inter...

BACKGROUND Hemoglobin C, D Punjab, E or S trait can interfere with hemoglobin A1c (HbA1c) results. We assessed whether they affect results obtained with 12 current assay methods. METHODS Hemoglobin AA (HbAA), HbAC, HbAD Punjab, HbAE and HbAS samples were analyzed on one enzymatic, nine ion-exchange HPLC and two Capillary Electrophoresis methods. Trinity ultra(2) boronate affinity HPLC was the...